Scarica l'app Stockscreener
0.495
5.88%
0.0275
Pre-mercato:
.50
0.005
+1.01%
Precedente Chiudi:
$0.4675
Aprire:
$0.4693
Volume 24 ore:
1.40M
Relative Volume:
0.41
Capitalizzazione di mercato:
$24.50M
Reddito:
-
Utile/perdita netta:
$-29.77M
Rapporto P/E:
-0.0324
EPS:
-15.2954
Flusso di cassa netto:
$-24.23M
1 W Prestazione:
+2.06%
1M Prestazione:
+36.06%
6M Prestazione:
-40.29%
1 anno Prestazione:
-79.11%
Intervallo 1D:
$0.459
$0.50
Intervallo di 1 settimana:
$0.459
$0.525
Portata 52W:
$0.25
$3.6499
Moleculin Biotech Inc Stock (MBRX) Company Profile
Nome
Moleculin Biotech Inc
Settore
Industria
Telefono
713-300-5160
Indirizzo
5300 MEMORIAL DRIVE, HOUSTON, TX
Confronta MBRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MBRX
Moleculin Biotech Inc
|
0.495 | 23.14M | 0 | -29.77M | -24.23M | -15.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Moleculin Biotech Inc Stock (MBRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-09 | Ripresa | H.C. Wainwright | Buy |
| 2025-02-12 | Downgrade | Maxim Group | Buy → Hold |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
Moleculin Biotech Inc Borsa (MBRX) Ultime notizie
Why Moleculin Biotech Inc. stock is rated strong buy2025 Short Interest & Intraday High Probability Setup Alerts - newser.com
Can Moleculin Biotech Inc. stock deliver surprise earnings beat2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com
Can Moleculin Biotech Inc. (MOL) stock stage a strong rebound this quarterPortfolio Update Report & Real-Time Chart Pattern Alerts - newser.com
Will Moleculin Biotech Inc. stock go up soonJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
Top chart patterns to watch in Moleculin Biotech Inc.2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - newser.com
Visual analytics tools that track Moleculin Biotech Inc. performanceTrade Volume Summary & Fast Entry and Exit Trade Plans - newser.com
Can machine learning forecast Moleculin Biotech Inc. recovery2025 Market Trends & Risk Adjusted Swing Trade Ideas - newser.com
Is Moleculin Biotech Inc. stock attractive after correction2025 Year in Review & Fast Gain Stock Trading Tips - newser.com
Real time social sentiment graph for Moleculin Biotech Inc.2025 Big Picture & Entry and Exit Point Strategies - newser.com
Is Moleculin Biotech Inc. stock overvalued by current metrics2025 Fundamental Recap & Short-Term High Return Strategies - newser.com
Technical signs of recovery in Moleculin Biotech Inc.Weekly Gains Report & Stepwise Entry/Exit Trade Alerts - newser.com
Moleculin Biotech Inc. stock momentum explainedJuly 2025 WrapUp & Accurate Trade Setup Notifications - newser.com
Analyzing Moleculin Biotech Inc. with multi timeframe chartsWeekly Profit Summary & Long-Term Capital Growth Strategies - newser.com
How to escape a deep drawdown in Moleculin Biotech Inc.2025 Big Picture & Free Daily Entry Point Trade Alerts - newser.com
How to build a dashboard for Moleculin Biotech Inc. stockInflation Watch & Safe Entry Point Identification - newser.com
Will earnings trigger a reversal in Moleculin Biotech Inc.Trade Performance Summary & Low Drawdown Investment Ideas - newser.com
Can Moleculin Biotech Inc. (MOL) stock hold up in economic slowdown2025 Trading Volume Trends & Free Weekly Chart Analysis and Trade Guides - newser.com
Moleculin Biotech Secures $6 Million Through Warrant Agreement - MSN
Moleculin Biotech (NASDAQ:MBRX) Stock Rating Lowered by Wall Street Zen - Defense World
MBRXMoleculin Reports Second Quarter 2025 Financial Results and Highlights - ADVFN
Moleculin receives notice of intent to grant new European patent for Annamycin - MSN
Moleculin Biotech Inc Azioni (MBRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Moleculin Biotech Inc Azioni (MBRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| KLEMP WALTER V | CEO and President |
Jun 23 '25 |
Buy |
0.37 |
675,675 |
250,000 |
743,607 |
5.15%
1.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):